A Non-Interventional Study Observing Short-Term Progression in Geographic Atrophy (GA)

Part of paid clinical trials in Mountain View, California.

Sponsor
Complement Therapeutics
Study ID
NCT07144137
Status
Recruiting
Apply to this trial

Conditions

  • Geographic Atrophy Secondary to Age-related Macular Degeneration

Eligibility Criteria

Sex
ALL
Age
55 Years - N/A
Healthy Volunteers
Not accepted

Study Details

This is a non-interventional, observational study to provide insights into the short-term progression of GA secondary to AMD in participants aged ≥55 years. This is a multi-center, non-interventional, observational study which aims to identify participants who have progressive GA to allow quantification of structural and functional parameters that characterize the progression of GA, and to investigate whether these correlate with genetic or lifestyle factors.

Key Dates

Start date
Jul 30, 2025
Status verified
Jun 2026
Primary completion
Mar 31, 2027
Completion
Jun 30, 2027

Study Design

Enrollment
75 participants (estimated)

Primary Outcome Measure

Short-term GA Progression [ Time Frame: Baseline, Month 3, Month 6 ]

Central Contacts

Locations (6)

FacilityCityStateZIPSite coordinators
Northern California Retina Vitreous Associates Medical GroupMountain ViewCalifornia94040-
Midwest Eye InstituteCarmelIndiana46032-
Sierra Eye AssociatesRenoNevada89502-
Mid Atlantic RetinaBethlehemPennsylvania18017-
Retina Foundation of the SouthwestDallasTexas75231-
Gundersen Health SystemLa CrosseWisconsin54601-

Find similar trials in Mountain View, CA

By research site
Northern California Retina Vitreous Associates Medical Group· Mountain View, CAMidwest Eye Institute· Carmel, INSierra Eye Associates· Reno, NVMid Atlantic Retina· Bethlehem, PARetina Foundation of the Southwest· Dallas, TXGundersen Health System· La Crosse, WI

Related Studies